On March 31, 2023, U.S. District Judge Ronnie Abrams of the Southern District of New York dismissed a putative securities class action against CarLotz, Inc. (CarLotz), and certain of its officers and directors on the grounds...more
5/26/2023
/ Board of Directors ,
Class Action ,
Conflicts of Interest ,
Corporate Officers ,
Cryptocurrency ,
False Statements ,
Fraud ,
Initial Public Offering (IPO) ,
Misleading Statements ,
Pump and Dump ,
Putative Class Actions ,
Securities ,
Securities Act of 1933 ,
Securities and Exchange Commission (SEC) ,
Securities Exchange Act ,
Shareholders ,
Special Purpose Acquisition Companies (SPACs) ,
Standing ,
Statute of Limitations
On July 12, 2022, Twitter, Inc. brought a civil action in the Delaware Court of Chancery against Elon Musk, the co-founder and CEO of Tesla Motors, Inc., for breach of contract in an attempt to force Musk to complete his...more
7/28/2022
/ Acquisitions ,
Attorney-Client Privilege ,
Breach of Contract ,
Class Action ,
Criminal Convictions ,
Cryptoassets ,
Cryptocurrency ,
Discovery Disputes ,
Elon Musk ,
Gaming ,
Insider Trading ,
Merger Agreements ,
Securities ,
Securities and Exchange Commission (SEC) ,
Securities Exchange Act ,
Securities Fraud ,
Specific Performance ,
Spoofing ,
Twitter
On April 19, 2022, Judge James R. Knepp II of the U.S. District Court for the Northern District of Ohio approved consent judgments against biotechnology firm Rising Biosciences, Inc. and its CEO Arthur Hall for violations of...more
5/4/2022
/ Class Action ,
Consent Order ,
Coronavirus/COVID-19 ,
Elon Musk ,
Failure To State A Claim ,
False Statements ,
Marriott ,
Misleading Statements ,
Ponzi Scheme ,
Public Statements ,
Putative Class Actions ,
Restraining Orders ,
Rule 10(b) ,
Rule 10b-5 ,
Securities Exchange Act ,
Securities Violations ,
Tesla
Northern District of Illinois Grants Motion for Partial Reconsideration of Summary Judgment Decision Regarding Whether Former Walgreens CFO’s Statements Were Actionable; Securities Fraud Claims Against Chicken Producer for...more
3/23/2022
/ Antitrust Violations ,
Bid Rigging ,
Bristol-Myers Squibb ,
CEOs ,
CFOs ,
Class Action ,
Clinical Trials ,
Criminal Prosecution ,
Department of Justice (DOJ) ,
Dismissal With Prejudice ,
Dismissals ,
False Statements ,
Guilty Pleas ,
Investors ,
Misleading Statements ,
Partial Summary Judgments ,
Pharmaceutical Industry ,
Price-Fixing ,
Private Securities Litigation Reform Act of 1995 ,
PSLRA ,
Public Statements ,
Safe Harbors ,
Scienter ,
Securities Exchange Act of 1934 ,
Securities Fraud ,
Securities Litigation ,
Securities Violations ,
Share Price ,
Stock Drop Litigation ,
Walgreens
Delaware Federal Court Dismisses Shareholder Derivative Suit Concerning Lack of Board Diversity; California Federal Court Dismisses Shareholder Class Action Against Sorrento Therapeutics Regarding COVID-19 Treatment; Delaware...more
12/23/2021
/ Board of Directors ,
Cannabis-Related Businesses (CRBs) ,
Class Action ,
Coronavirus/COVID-19 ,
Derivative Suit ,
Discovery ,
Discovery Violations ,
Dismissals ,
Diversity ,
False Statements ,
Investment Fraud ,
Investors ,
Misleading Statements ,
Misrepresentation ,
Pharmaceutical Industry ,
Popular ,
Putative Class Actions ,
Rule 10b-5 ,
Scienter ,
Securities Exchange Act of 1934 ,
Securities Violations ,
Shareholder Litigation ,
Shareholders